Rare Diseases
Latest News
Scurvy: A Diagnosis Still Relevant Today
Scurvy can cause mucosal and gastric hemorrhages, and may be linked to poor diet or bariatric surgery.
From the Journals
Dermatomyositis Cancer Screening Guidelines Get Real-World Validation
Most of the cancers were detected using standard age- and sex-based cancer screenings, suggesting the potential for overscreening in this...
News from the FDA/CDC
FDA Approves First Engineered Cell Therapy for a Solid Tumor
This T-cell receptor therapy modifies existing receptors to recognize an array of antigens on the surface of cancer cells.
Latest News
Dermatofibrosarcoma Protuberans More Common In Black Patients, Analysis Finds
Researchers used the National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) registry from 2000 through 2018 to provide a...
Latest News
VEXAS Syndrome: Study Highlights Cutaneous Symptoms
Affected individuals exhibit a wide range of manifestations, including cytopenia/myelodysplasia, multiorgan systemic inflammation, and cutaneous...
Commentary
Unleashing Our Immune Response to Quash Cancer
“It’s astounding how devious cancer cells and tumor tissue can be.”
From the Journals
Unexplained collapse unveils rare blood disorder
Acquired TTP often appears to arise in connection with either an immune trigger, such as a viral infection, or immune dysregulation associated...
News
FDA approves first tx for rare, deadly clotting disorder
First drug to treat TTP. a rare, lethal blood clotting disorder, has been greenlighted by the FDA.
Commentary
Male patients with breast cancer: Special considerations and gender-specific concerns
Even the materials that we have are gender specific. I think those things all together can certainly contribute to a man feeling like a fish out...
Conference Coverage
Triple therapy boosts anaplastic thyroid cancer survival
"The very long median overall survival in the study's neoadjuvant group is quite remarkable for a group of patients who used to have a very poor...
Latest News
Mohs found to confer survival benefit in localized Merkel cell carcinoma
Results provide “preliminary data suggesting that treatment of localized, early-stage MCC with MMS may result in the most optimal patient survival...